drugset / Trial / NCT02324153

Ramelteon in the Prevention of Post-operative Delirium

NCT02324153

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This trial focuses on a Phase II randomized masked clinical trial testing the effectiveness and safety of peri-operative administration of ramelteon, a melatonin agonist in the prevention of postoperative delirium.

Timeline

Start
2017-03-24
Primary completion
2019-06-26
Completion
2019-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 8 mg Oral
Background Riboflavin Other / unclassified 100 mg

Indications